In March 2025, the company introduced new plans to get a direct-to-buyer offering of its Wegovy weight loss drug. The company set up a new pharmacy, termed NovoCare, which would cost shoppers $499 per month for usage of the drug, fewer than half the cost of the drug by means of other pharmaceuti